A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser

Launched by MASSACHUSETTS GENERAL HOSPITAL · Mar 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different types of lasers—Difference Frequency Generation (DFG) laser and CO2 laser—to see which one helps reduce pain and improve wound healing better. The researchers want to find out if the DFG laser is a safer option with fewer side effects and less recovery time for patients. If you are in good general health, over 18 years old, and can read and understand English, you might be eligible to participate in this study.

Participants will need to provide consent and follow the study rules, but they cannot have certain skin conditions or a history of drug or alcohol abuse, among other specific criteria. If you join the study, you can expect to undergo treatments with either laser and have your pain levels and wound healing monitored. This research could help improve laser treatments in the future, making them safer and more effective for everyone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects must be able and willing to provide written informed consent and comply with the requirements of the study protocol;
• • Subjects must be in good general health, based on answers provided during the screening visit;
• • Subjects must be able to read and understand English.
• • Subjects must be above the age of 18.
• • Subjects must have no history of skin conditions that affect the integrity of the skin barrier.
• Exclusion Criteria:
• • Are pregnant or lactating;
• • Have a history of drug or alcohol abuse or have reported habitual alcohol intake greater than 2 standard drinks per day \[e.g., 2 beers, 2 glasses of wine, or 2 mixed drinks\];
• • Are smoking or have a history of smoking;
• • Presence of eczema, psoriasis, skin wounds or ulcers, or any other skin disease on the thighs;
• • Have birth marks, tattoos, scars, or any other disfiguration of the skin in the skin area of interest;
• • Presence of sunburn or tan in the treatment area;
• • Use of any topical application of retinoids in the area of interest or systemic retinoids in the past 6 months;
• • Use of any prescription topical medication, such as corticosteroids or hydroquinone on the skin area of interest in the past 6 months;
• • History of blood-clotting abnormality;
• • History of keloid formation or hypertrophic scarring;
• • History of allergic reaction to local anesthesia, aluminum chloride, and/or glycerol;
• • Investigator, interfere with study evaluations or pose a risk to subject safety during the study;
• • Exhibits any clinical conditions or takes any medication which in the opinion of the investigator may interfere with the study or pose a risk to subject safety during the study;
• • Is not able to follow study protocol.